BIOMAT Database Logo BIOMAT Database Logo

Antiviral efficacy of Imexon in the Rauscher murine retrovirus AIDS model. 1990

M A Chirigos, and M A Ussery, and J T Rankin, and D Herrmann, and U Bicker, and P L Black
United States Army Medical Research Institute of Infectious Diseases, Ft. Detrick, MD.

UI MeSH Term Description Entries
D007155 Immunologic Factors Biologically active substances whose activities affect or play a role in the functioning of the immune system. Biological Response Modifier,Biomodulator,Immune Factor,Immunological Factor,Immunomodulator,Immunomodulators,Biological Response Modifiers,Biomodulators,Factors, Immunologic,Immune Factors,Immunological Factors,Modifiers, Biological Response,Response Modifiers, Biological,Factor, Immune,Factor, Immunological,Factors, Immune,Factors, Immunological,Modifier, Biological Response,Response Modifier, Biological
D007659 Ketones Organic compounds containing a carbonyl group Ketone
D007942 Leukemia, Experimental Leukemia induced experimentally in animals by exposure to leukemogenic agents, such as VIRUSES; RADIATION; or by TRANSPLANTATION of leukemic tissues. Experimental Leukemia,Experimental Leukemias,Leukemia Model, Animal,Leukemias, Experimental,Animal Leukemia Model,Animal Leukemia Models,Leukemia Models, Animal
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D011925 Rauscher Virus A strain of MURINE LEUKEMIA VIRUS associated with mouse tumors similar to those caused by the FRIEND MURINE LEUKEMIA VIRUS. It is a replication-competent murine leukemia virus. It can act as a helper virus when complexing with a defective transforming component, RAUSCHER SPLEEN FOCUS-FORMING VIRUS. Rauscher leukemia virus,Rauscher leukemia viruses,Virus, Rauscher,leukemia viruses, Rauscher
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D005260 Female Females
D006588 Hexanones 6-carbon straight-chain or branched ketones. Butyl Methyl Ketones,Ethyl Propyl Ketones,Ketones, Butyl Methyl,Ketones, Ethyl Propyl,Methyl Ketones, Butyl,Propyl Ketones, Ethyl
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

M A Chirigos, and M A Ussery, and J T Rankin, and D Herrmann, and U Bicker, and P L Black
Use of a neonatal murine retrovirus model to evaluate the long-term efficacy and toxicity of antiviral agents.
January 1990, Annals of the New York Academy of Sciences,
M A Chirigos, and M A Ussery, and J T Rankin, and D Herrmann, and U Bicker, and P L Black
Antiviral effect of haloperidol on Rauscher murine leukemia virus.
January 1980, Archiv fur Geschwulstforschung,
M A Chirigos, and M A Ussery, and J T Rankin, and D Herrmann, and U Bicker, and P L Black
Antiviral efficacy and toxicity of ribavirin and foscarnet each given alone or in combination in the murine AIDS model.
March 1997, Toxicology and applied pharmacology,
M A Chirigos, and M A Ussery, and J T Rankin, and D Herrmann, and U Bicker, and P L Black
Treatment of the murine, retrovirus-induced lymphoproliferative immunodeficiency disease (LP-BM5) in C57BL/10 mice with the immunomodulator Imexon.
May 1992, AIDS research and human retroviruses,
M A Chirigos, and M A Ussery, and J T Rankin, and D Herrmann, and U Bicker, and P L Black
A murine retrovirus model for studies of the role of cofactors and ethanol in AIDS development.
January 1990, NIDA research monograph,
M A Chirigos, and M A Ussery, and J T Rankin, and D Herrmann, and U Bicker, and P L Black
Abnormal selection of antibody repertoires in retrovirus-induced murine AIDS.
November 1993, Journal of immunology (Baltimore, Md. : 1950),
M A Chirigos, and M A Ussery, and J T Rankin, and D Herrmann, and U Bicker, and P L Black
Impact of dosing schedule upon suppression of a retrovirus in a murine model of AIDS encephalopathy.
March 1994, Antimicrobial agents and chemotherapy,
M A Chirigos, and M A Ussery, and J T Rankin, and D Herrmann, and U Bicker, and P L Black
Antiviral efficacy and toxicity of ribavirin in murine acquired immunodeficiency syndrome model.
August 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association,
M A Chirigos, and M A Ussery, and J T Rankin, and D Herrmann, and U Bicker, and P L Black
Antileukaemic and antiviral effect of chloramphenicol and rifampicin combination in the therapy of Rauscher murine leukaemia.
January 1974, Folia biologica,
M A Chirigos, and M A Ussery, and J T Rankin, and D Herrmann, and U Bicker, and P L Black
Antileukaemic and antiviral effect of chloramphenicol and rifampicin combination in the therapy of Rauscher murine leukaemia.
January 1974, Folia biologica,
Copied contents to your clipboard!